Generics giant takes on top-seller

Arrotex will represent Amgen's osteoporosis treatment Prolia under a new partnership that aims to "broaden opportunities" for one of Australia's highest reimbursed drugs.

To see the whole article please log in.

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here